SURMODICS INC — Director's Dealing 2025

Nov 19, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2025-11-19

Reporting Person: KNIGHT SUSAN E (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-11-19	Common Stock	D	37240	—	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-11-19	Employee Stock Option (right to buy)	$55.24	D	3634	Disposed	2026-02-13	Common Stock (3634)	Direct
2025-11-19	Employee Stock Option (right to buy)	$39.58	D	4548	Disposed	2027-02-13	Common Stock (4548)	Direct
2025-11-19	Employee Stock Options (right to buy)	$53.86	D	3196	Disposed	2028-02-11	Common Stock (3196)	Direct
2025-11-19	Employee Stock Option (right to buy)	$41.81	D	3555	Disposed	2029-02-10	Common Stock (3555)	Direct
2025-11-19	Employee Stock Option (right to buy)	$28.98	D	5040	Disposed	2030-02-09	Common Stock (5040)	Direct
2025-11-19	Employee Stock Option (right to buy)	$31.89	D	4155	Disposed	2031-02-08	Common Stock (4155)	Direct

Footnotes

F1: Pursuant to that certain Merger Agreement, dated as of May 28, 2024, by and among the Surmodics, Inc. (the "Issuer"), BCE Parent, LLC, ("Parent"), and BCE Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with Issuer surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of the Issuer's common stock, par value $0.05 per share ("Common Stock"), that was issued and outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive $43.00 per share in cash, without interest and subject to any applicable tax withholdings (the "Merger Consideration"). All outstanding restricted stock units ("RSUs") held by the reporting person vested immediately prior to the Effective Time and the reporting person is entitled to receive the Merger Consideration for such vested RSUs.

F2: As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Common Stock.

F3: Pursuant to the Merger Agreement, at the Effective Time, this unexercised stock option ("Option") was cancelled and automatically converted into the right to receive an amount in cash (without interest) equal to the product of (a) the aggregate number of shares of Common Stock subject to the Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over such Option's applicable per share exercise price, subject to any required tax withholdings.